Free Trial

AlloVir (ALVR) SEC Filings & 10K Form

AlloVir logo
$0.40 -0.05 (-10.22%)
(As of 12/20/2024 05:31 PM ET)

Recent AlloVir SEC Filings

DateFilerForm TypeView
12/20/2024
3:21 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:23 PM
AlloVir (Subject)
Form 425
12/11/2024
4:07 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:37 AM
AlloVir (Filer)
Form S-4
Registration statement under Securities Act of 1933  
12/06/2024
8:50 PM
AlloVir (Subject)
Form 425
12/06/2024
6:23 AM
AlloVir (Filer)
Form DEF 14A
11/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:05 PM
AlloVir (Subject)
Form 425
11/08/2024
3:06 PM
AlloVir (Subject)
Form 425
11/08/2024
3:09 PM
AlloVir (Subject)
Form 425
11/08/2024
3:10 PM
AlloVir (Subject)
Form 425
11/08/2024
7:26 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:33 AM
AlloVir (Subject)
Form 425
11/05/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

10/03/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
10:14 AM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
8:05 AM
AlloVir (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2024
5:25 PM
AlloVir (Subject)
Invus Global Management, LLC (Filed by)
Form SC 13G/A
07/23/2024
3:25 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:27 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:28 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:28 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
6:30 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
6:30 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
6:30 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
4:10 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:24 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2024
3:35 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:33 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:33 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:35 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
3:00 PM
AlloVir (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
I was wrong. Dead wrong. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

05/03/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/23/2024
3:05 PM
AlloVir (Filer)
Form DEF 14A
04/23/2024
3:06 PM
AlloVir (Filer)
Form DEFA14A
04/23/2024
3:08 PM
AlloVir (Filer)
Form ARS
04/23/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALVR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners